ArticleInternational journal of molecular sciences2023

Identification and Biological Validation of a Chemokine/Chemokine Receptor-Based Risk Model for Predicting Immunotherapeutic Response and Prognosis in Head and Neck Squamous Cell Carcinoma.

Ye Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.